Biomarkers For Inflammatory Response

Abstract

An in-vitro method for the prediction, prognosis and/or diagnosis of an inflammatory response associated with a condition or disease such as schizophrenia in a subject, the method comprising determining in a sample of a subject the level of 25-hydroxy vitamin D3, preferably in combination with the level of least one biomarker wherein the at least one biomarker is selected from innate chemokine (IL-8) and matrix metalloproteinase (MMP-9); and comparing the levels of said 25-hydroxy vitamin D3 and at least one biomarker to a control level of 25-hydroxy vitamin D3 and the at least one biomarker respectively in order to determine a positive or negative prediction, prognosis and/or diagnosis of said inflammatory response indicating an associated condition or disease, such as schizophrenia.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 24, 2014
  • Application: Jun 17, 2014
    WO IB 2014062299 W
  • Priority: Jun 17, 2013
    GB GB 201310734 A

Download Citation


Sign in to the Lens

Feedback